Announcing PIPseq V, Fluent’s Newest Breakthrough in Single-Cell Analysis

News

Three Watertown Biotech Companies Showcase Boston Area’s Thriving Innovation Ecosystem

Watertown, MA – June 12, 2024 – In the heart of Massachusetts’ life sciences supercluster, Watertown has emerged as a vibrant hub propelling innovation. Two companies, Fluent BioSciences and 7 Traits Genomics, showcase the region’s dynamic ecosystem of entrepreneurship, and technological advancement. Having incubated at Cambridge Scientific Labs, Fluent BioSciences pioneered groundbreaking single-cell transcriptomics technology […]

Read More

Fluent BioSciences Debuts PIPseq™ V with Unique Molecular Counting Strategy

Novel TruID™ method Increases transcript yield and overall assay sensitivity. Watertown, MA, May 29, 2024 Fluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3′ Single Cell RNA Sequencing Kits. This new release marks a significant advancement in molecular quantification, demonstrating our commitment […]

Read More

Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits powered by Ultima Genomics sequencing, prototype kits now shipping

Watertown, MA, March 21, 2024 – Fluent BioSciences, a cutting-edge life sciences company leading the charge in revolutionizing single-cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical […]

Read More

Fluent Biosciences announces early access availability of transformative direct-guide capture for single cell analysis for complex CRISPR screening in Particle-templated Instant Partitions (PIPseq-CRISPR)

Watertown, MA, March 21, 2024 – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces early access availability of new kits and reagents for direct CRISPR guide capture in particle templated instant partitions (PIPseq-CRISPR).  The PIPseq platform provides an instrument and microfluidics-free approach for single cell […]

Read More

Breaking Barriers: Fluent BioSciences and Element Biosciences Collaborate to Enhance scRNA-seq Access

WATERTOWN, Mass., Dec. 19, 2023 /PRNewswire/ — Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are excited to announce their collaboration to enhance the accessibility and scalability of single-cell RNA sequencing (scRNA-seq). Single-cell RNA sequencing has been a crucial tool in unraveling cellular and molecular diversity within […]

Read More

Pioneering Scalable Single Cell RNA Sequencing: A Partnership Announced with Fluent BioSciences and Singular Genomics®

WATERTOWN, Mass., Nov. 2, 2023 /PRNewswire/ — Fluent BioSciences, a cutting-edge life science company transforming single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions, is excited to announce a partnership with Singular Genomics, a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Together, they unveil the compatibility […]

Read More

Fluent BioSciences Awarded NIH SBIR Grant to Revolutionize Single Cell Analysis

WATERTOWN, Mass., Sept. 12, 2023 /PRNewswire/ — Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical […]

Read More

Fluent BioSciences Partners with Genspace to Unleash the Power of PIPseq™: Empowering Community Scientists to Transform Genomic Research

WATERTOWN, Mass., May 30, 2023 /PRNewswire/ — Fluent BioSciences, a life science tools company, delivering single-cell technology to laboratories across the United States and abroad, collaborates with Genspace by sponsoring a community science workshop in Brooklyn, NY. They hope to empower scientists by breaking down barriers in a field which has previously been marred by prohibitive costs and expertise requirements. At […]

Read More

Fluent BioSciences Partners with GenomeWeb and NYU Grossman School of Medicine’s Liddelow Lab to Host Webinar on Revolutionary PIPseq scRNA-Seq Technology with Upcoming bioRxiv Publication

Watertown, MA, May 16, 2023 – Fluent BioSciences, a top life sciences company focusing on bringing the benefits of high-quality single-cell biology to all laboratories by offering scalable, cost-effective, and easy-to-implement scRNA-seq solutions, in collaboration with GenomeWeb and the Liddelow Lab, will host a webinar to explore the use of PIPseq, an innovative single-cell RNA […]

Read More

Fluent BioSciences Releases Comprehensive White Paper Highlighting Increased Performance Metrics with the Latest v4.0 PIPseq Single Cell RNA Sequencing Kits

Fluent BioSciences, a leading life sciences company focused on revolutionizing single cell analysis through simple, cost effective and scalable solutions, has published a white paper highlighting the performance improvements of the recently announced v4.0 chemistry as compared to the previous v3.0 chemistry. The v4.0 chemistry enables users to achieve higher capture rates, significantly higher sensitivity […]

Read More